HABEKACIN Trademark

Trademark Overview

On Wednesday, July 8, 2015, a trademark application was filed for HABEKACIN with the United States Patent and Trademark Office. The USPTO has given the HABEKACIN trademark a serial number of 79173472. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, August 30, 2018. This trademark is owned by Meiji Seika Pharma CO., Ltd.. The HABEKACIN trademark is filed in the Pharmaceutical Products category with the following description:

Antibiotics
habekacin

General Information

Serial Number79173472
Word MarkHABEKACIN
Filing DateWednesday, July 8, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, August 30, 2018
Registration Number4957965
Registration DateTuesday, May 17, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Goods and ServicesAntibiotics
Translation of Words in MarkThe wording HABEKACIN has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, August 30, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeiji Seika Pharma CO., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameMeiji Seika Pharma CO., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameMeiji Seika Pharma CO., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, March 22, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, March 22, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 21, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, April 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 22, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 22, 2016FINAL DISPOSITION PROCESSED
Wednesday, August 17, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 17, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Friday, February 26, 2016NOTIFICATION PROCESSED BY IB
Wednesday, February 10, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 10, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, January 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 22, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 21, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 21, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 8, 2015REFUSAL PROCESSED BY IB
Wednesday, October 21, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 21, 2015REFUSAL PROCESSED BY MPU
Tuesday, October 20, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 19, 2015NON-FINAL ACTION WRITTEN
Monday, October 19, 2015ASSIGNED TO EXAMINER
Friday, October 9, 2015APPLICATION FILING RECEIPT MAILED
Monday, October 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 1, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

habekacin antibiotics